UBS Group AG: Blackwell's fourth quarter may generate revenue of $9 billion, maintains NVIDIA Corporation's (NVDA.US) target price at $185.
UBS analyst Timothy Arcuri maintains Nvidia's target price at $185, essentially unchanged.
NVIDIA Corporation's stock (NVDA.US) has remained relatively flat since its last quarterly earnings report, but UBS Group AG predicts that the company's revenue from its latest production line will exceed previous expectations due to optimistic sentiment around the Blackwell chip. UBS Group AG analyst Timothy Arcuri has maintained a target price of $185 for NVIDIA Corporation.
In a report to clients, Arcuri wrote, "First, we believe that the yield on the Blackwell chip has improved, and the combination of the fourth quarter (January) and the first quarter (April) is rapidly shifting from Hopper to Blackwell." Additionally, based on Foxconn's latest performance, any hardware issues that NVIDIA Corporation may face have recently seen significant improvement as the company is delivering B200 and GB200 processors to partners, with rack deliveries already underway.
Arcuri added, "Therefore, we now see revenue from Blackwell in January at around $9 billion (compared to previous expectations of around $5 billion, with supply chain capacity supporting up to $14 billion), but we expect a decline in Hopper in January. We forecast revenue of $42 billion (data center) for the fourth quarter (January) and still $47 billion for the first quarter (April)."
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025